The access to paired samples of PBMC and SFMC for RA and PsA patients before treatment enabled us to show that the decrease of CD73 expression and CD39 up-regulation on total Teff was even more dramatic at the site of inflammation both in RA (Figure 1G) and in PsA (Figure S2C). Here, NT5E is linked to rheumatoid arthritis.